BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30303435)

  • 21. Multimodal Imaging of Parry Romberg Syndrome-associated Panuveitis: A Case Report and Review of Literature.
    Duan J; Li M; Chai Q; Zhou N; Hao Y
    Ocul Immunol Inflamm; 2021 Jan; 29(1):179-186. PubMed ID: 31577463
    [No Abstract]   [Full Text] [Related]  

  • 22. TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.
    Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Sainz de la Maza M; Adán A
    Retina; 2018 Jul; 38(7):1361-1370. PubMed ID: 28520640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multispectral image analysis in Vogt-Koyanagi-Harada disease.
    Huang G; Peng J; Ye Z; Kijlstra A; Zhang D; Yang P
    Acta Ophthalmol; 2018 Jun; 96(4):411-419. PubMed ID: 29220112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
    Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
    Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
    Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
    Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinal Pigment Epithelium Detachment in Acute Vogt-Koyanagi-Harada Disease: An Unusual Finding at Presentation.
    Khochtali S; Ksiaa I; Megzari K; Khairallah M
    Ocul Immunol Inflamm; 2019; 27(4):591-594. PubMed ID: 29513616
    [No Abstract]   [Full Text] [Related]  

  • 28. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.
    Kempen JH; Van Natta ML; Altaweel MM; Dunn JP; Jabs DA; Lightman SL; Thorne JE; Holbrook JT;
    Am J Ophthalmol; 2015 Dec; 160(6):1133-1141.e9. PubMed ID: 26386159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in Central Macular Thickness and Retinal Nerve Fiber Layer Thickness in Eyes with Vogt-Koyanagi-Harada Disease: A 2-Year Follow-Up Study.
    Han YS; Shin KS; Lee WH; Kim JY
    Ophthalmologica; 2018; 239(2-3):143-150. PubMed ID: 29339644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tuberculin skin-test-induced uveitis in the absence of tuberculosis.
    Burgoyne CF; Verstraeten TC; Friberg TR
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):232-6. PubMed ID: 1869057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical Coherence Tomography-Based Quantification of Photoreceptor Injury and Recovery in Vogt-Koyanagi-Harada Uveitis.
    Bae SS; Forooghian F
    Ocul Immunol Inflamm; 2017 Jun; 25(3):338-343. PubMed ID: 26903383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescein angiography and visual acuity in active uveitis with Behçet disease.
    Yu HG; Kim MJ; Oh FS
    Ocul Immunol Inflamm; 2009; 17(1):41-6. PubMed ID: 19294573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presumed tuberculosis-associated uveitis: rising incidence and widening criteria for diagnosis in a non-endemic area.
    Krassas N; Wells J; Bell C; Woodhead M; Jones N
    Eye (Lond); 2018 Jan; 32(1):87-92. PubMed ID: 28776591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vogt-Koyanagi-Harada syndrome.
    Moorthy RS; Inomata H; Rao NA
    Surv Ophthalmol; 1995; 39(4):265-92. PubMed ID: 7725227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular Autoimmune Systemic Inflammatory Infectious Study - Report 3: Posterior and Panuveitis.
    Lee JH; Mi H; Lim R; Ho SL; Lim WK; Teoh SC; Agrawal R
    Ocul Immunol Inflamm; 2019; 27(1):89-98. PubMed ID: 28991501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P; Sun M
    Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
    Soheilian M; Aletaha M; Yazdani S; Dehghan MH; Peyman GA
    Ocul Immunol Inflamm; 2006 Apr; 14(2):91-8. PubMed ID: 16597538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vogt-Koyanagi-Harada disease in children.
    Abu El-Asrar AM; Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D
    Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-wide-field angiography findings in acute Vogt-Koyanagi-Harada disease.
    Kim P; Sun HJ; Ham DI
    Br J Ophthalmol; 2019 Jul; 103(7):942-948. PubMed ID: 30100554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral Granulomatous Panuveitis in A Patient with COVID-19.
    Ozdemir Yalcinsoy K; Ozdamar Erol Y; Ozdal PC
    Ocul Immunol Inflamm; 2023 Aug; 31(6):1206-1209. PubMed ID: 35486665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.